HDACi: The Columbus’ Egg in Improving Cancer Treatment and Reducing Neurotoxicity?

SIMPLE SUMMARY: The inhibitors of histone deacetylases (HDACs) enzymes are an emerging class of drugs proposed for the treatment of several tumors. Despite a general antineoplastic effectiveness, HDACs inhibitors showed conflicting results concerning their effects on the nervous system. Such a discr...

Descripción completa

Detalles Bibliográficos
Autores principales: Squarzoni, Angelica, Scuteri, Arianna, Cavaletti, Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654569/
https://www.ncbi.nlm.nih.gov/pubmed/36358670
http://dx.doi.org/10.3390/cancers14215251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654569/
https://www.ncbi.nlm.nih.gov/pubmed/36358670
http://dx.doi.org/10.3390/cancers14215251

Ejemplares similares